Skip to main content
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1998;6(1):3–7. doi: 10.1002/(SICI)1098-0997(1998)6:1<3::AID-IDOG2>3.0.CO;2-0

Metronidazole vaginal gel 0.75% (MetroGel-Vaginal): a brief review.

A M Wain 1
PMCID: PMC1784772  PMID: 9678140

Full Text

The Full Text of this article is available as a PDF (419.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper M. M., Barwin B. N., McLean W. M., McGilveray I. J., Sved S. Systemic absorption of metronidazole by the vaginal route. Obstet Gynecol. 1985 Jun;65(6):781–784. [PubMed] [Google Scholar]
  2. Cunningham F. E., Kraus D. M., Brubaker L., Fischer J. H. Pharmacokinetics of intravaginal metronidazole gel. J Clin Pharmacol. 1994 Nov;34(11):1060–1065. doi: 10.1002/j.1552-4604.1994.tb01981.x. [DOI] [PubMed] [Google Scholar]
  3. Edwards D. I. Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs. Br J Vener Dis. 1980 Oct;56(5):285–290. doi: 10.1136/sti.56.5.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fredricsson B., Hagström B., Nord C. E., Rane A. Systemic concentrations of metronidazole and its main metabolites after intravenous oral and vaginal administration. Gynecol Obstet Invest. 1987;24(3):200–207. doi: 10.1159/000298803. [DOI] [PubMed] [Google Scholar]
  5. Hillier S. L., Lipinski C., Briselden A. M., Eschenbach D. A. Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis. Obstet Gynecol. 1993 Jun;81(6):963–967. [PubMed] [Google Scholar]
  6. Lau A. H., Lam N. P., Piscitelli S. C., Wilkes L., Danziger L. H. Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives. Clin Pharmacokinet. 1992 Nov;23(5):328–364. doi: 10.2165/00003088-199223050-00002. [DOI] [PubMed] [Google Scholar]
  7. Livengood C. H., 3rd, McGregor J. A., Soper D. E., Newton E., Thomason J. L. Bacterial vaginosis: efficacy and safety of intravaginal metronidazole treatment. Am J Obstet Gynecol. 1994 Mar;170(3):759–764. doi: 10.1016/s0002-9378(94)70278-0. [DOI] [PubMed] [Google Scholar]
  8. Müller M. Action of clinically utilized 5-nitroimidazoles on microorganisms. Scand J Infect Dis Suppl. 1981;26:31–41. [PubMed] [Google Scholar]
  9. O'Reilly R. A. The stereoselective interaction of warfarin and metronidazole in man. N Engl J Med. 1976 Aug 12;295(7):354–357. doi: 10.1056/NEJM197608122950702. [DOI] [PubMed] [Google Scholar]
  10. Rosenblatt J. E., Edson R. S. Symposium on antimicrobial agents. Metronidazole. Mayo Clin Proc. 1987 Nov;62(11):1013–1017. doi: 10.1016/s0025-6196(12)65074-5. [DOI] [PubMed] [Google Scholar]
  11. Schwebke J. R. Metronidazole: utilization in the obstetric and gynecologic patient. Sex Transm Dis. 1995 Nov-Dec;22(6):370–376. [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES